Navigation Links
Frost & Sullivan Recognizes Lifeblood Medical for Its Innovation in Organ Preservation and Development of the Lifor(R) Solution
Date:10/27/2008

MOUNTAIN VIEW, Calif., Oct. 27 /PRNewswire/ -- Frost & Sullivan is pleased to present the 2008 North American Pharmaceuticals & Biotechnology Emerging Markets Healthcare Innovation Award to Lifeblood Medical. This is in recognition of the company's unique solution technology, which offers a myriad of advantages and has led to the development of Lifor(R), a breakthrough product for organ preservation solution. In addition to human organ preservation, Lifeblood Medical's technology has potential for a wide number of applications and presents a unique opportunity for the company to impact multiple emerging healthcare markets.

Current preservation solutions restrict the duration organs remain viable between harvesting and re-implantation. In addition to time, temperature constraints, cost effectiveness, increasing demand, and the need to protect against ischemia reperfusion injury are all characteristics which showcase the need for product and technology improvements in the area of organ preservation solutions.

"With Lifor, Lifeblood Medical has developed a product with capabilities and characteristics that positively differentiate from other organ transplant products both in the market and in visible development," says Frost & Sullivan Research Analyst Barath Shankar Subramanian. "By positioning focus in a high profile and underserved area of organ transplant through a highly innovative and flexible technology, Lifeblood Medical is at the forefront of product innovation in organ transplant and preservation."

A synthetic preservation medium containing cellular nutrients, Lifor is a non-animal protein oxygen and nanoparticle carrier. It can carry oxygen and nutrients to cells and tissues, helping them sustain metabolic processes and stay alive, a critical factor in organ transplantation. In comparison to existing organ preservation solutions that can preserve liver and kidney for 12 hours at hypothermic (below 20 C and typically at about 4 C)
'/>"/>

SOURCE Frost & Sullivan
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Supernanny Jo Frost Joins the Partnership for a Drug-Free America in Supporting Time To Talk(TM)
2. Masimo Corporation Receives a Frost & Sullivan 2007 Industry Best Practices Award for Pulse Oximetry Leadership
3. Panomics Inc.: Recipient of the Frost & Sullivan 2007 United States Drug Discovery Technologies Entrepreneurial Company of the Year Award
4. Novadaqs SPY Imaging System named Product of the Year by Frost and Sullivan
5. Gary Tschautscher of Nonin Medical, Inc. Receives CEO of 2007 for North American Patient Monitoring From Frost & Sullivan
6. Kelloggs Frosted Flakes Gold(TM) Helps Moms Get the Gold
7. MedApps Receives Prestigious Frost & Sullivan Award
8. Nancy Frost Joins Lawson-Hawks as Employee Benefits Vice President
9. Accurays CyberKnife System Receives 2008 North American Medical Devices Product of the Year Award From Frost & Sullivan
10. Help Your Kids Earn an A for Attentiveness with a Bowl of Frosted Mini- Wheats(R) Cereal for Breakfast
11. Therapy Could Save Limbs After Frostbite

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...e was equivalent to 113 chest X-rays, study finds ...More than half of patients who have abdominal/pelv... tests that expose them to extra radiation, U.S. r...l and pelvic series were performed on 500 patients...ere 30 to 50 years of age. The researchers conclud...
(Date:11/30/2009)...by Merck, the unique online and mobile tool empowe... treatment decisions ,, ARLINGTON, Va., Nov. 3...dy.com ), the #1 HIV/AIDS resource online, today l...ol offering HIV/AIDS-infected patients the ability...e tool, created with sponsorship from Merck, is av...
(Date:11/30/2009)... Switzerland, Nov. 30 Ty...ed that its 2010 annual general meeting of shareho... 3:00 p.m. Central European time at the Park Hyatt...Switzerland. Registered shareholders as of January...te at the annual general meeting. Additionally, i...
(Date:11/30/2009)...of development and extensive discussion in the sci...fficiency in Health Care (IQWiG) presents its meth...enefit. The Institute can now apply these methods ... Federal Joint Committee (G-BA). The method develo...tions to the GKV-Spitzenverband [National Associat...
(Date:11/30/2009)...K, Nov. 30 Reportlinker.com announ... in its catalogue: ,, Key Players and Innovati...s in ingredients, pharma, food and drinks ,, ...nd-Innovative-Start-Ups-in-Nutraceuticals-Emerging...html ,, Nutraceuticals are bioactive compounds...
Breaking Medicine News(10 mins):Health News:CT Scan Patients May Get Unnecessary Imaging 2Health News:TheBody.com Launches My Health Tracker, Enabling HIV-Positive Patients to Track Lab Results, Medications and Supplements 2Health News:IQWiG presents a method for evaluating the relation between cost and benefit 2Health News:IQWiG presents a method for evaluating the relation between cost and benefit 3Health News:IQWiG presents a method for evaluating the relation between cost and benefit 4Health News:IQWiG presents a method for evaluating the relation between cost and benefit 5Health News:Reportlinker Adds Key Players and Innovative Start-Ups in Nutraceuticals: Emerging Strategies in Ingredients, Pharma, Food and Drinks 2Health News:Reportlinker Adds Key Players and Innovative Start-Ups in Nutraceuticals: Emerging Strategies in Ingredients, Pharma, Food and Drinks 3Health News:Reportlinker Adds Key Players and Innovative Start-Ups in Nutraceuticals: Emerging Strategies in Ingredients, Pharma, Food and Drinks 4Health News:Reportlinker Adds Key Players and Innovative Start-Ups in Nutraceuticals: Emerging Strategies in Ingredients, Pharma, Food and Drinks 5Health News:Reportlinker Adds Key Players and Innovative Start-Ups in Nutraceuticals: Emerging Strategies in Ingredients, Pharma, Food and Drinks 6
... diff-associated disease (CDAD), otherwise known a...tridium difficile (C. diff) pathogen, has been the...unity. A new report released this month by the fe...000 and 2005. Additionally, the Association for ...
...ma Incorporated,(Nasdaq: VPHM ) reported today it...rch 31, 2008., Key events since December 31, 200...icipating in Phase 3 study of Camvia(TM) (maribavi... of maribavir in solid organ transplant patien...
...noptix, Inc.,(Nasdaq: GXDX ), a specialized labor...ny,s participation in the Bank of America 2008 Hea...Four Seasons Hotel in Las Vegas,Nev., May 13 - 15,...ing at approximately 9:20am PDT. They will provide...
...vely weaken specific muscles may provide an ...nes, SAN MATEO, Calif., April 30 BioForm Medical...red substantially all of the,assets of privately-h...tential sales-related milestone. This acquisition,...
...0 Few spices are as,treasured and avoided! A clov...ou eat it, don,t be surprised if even your friends...e find the smell of garlic disgusting, and,will pr...day life., Direct subscription via RSS-Feed or iT...
...rates Nationwide Elementary School Lunch ... Calif., April 30 Actress and mother Kimberly,Wil...eggies. She,s even,written a book about it. Henry ... today awarded 51,elementary schools each with a $...
Other Medicine News:Health News:Report raises C. diff concerns; yeast-based probiotic shown to help significantly reduce recurrence 2Health News:ViroPharma Incorporated Reports First Quarter 2008 Financial Results 2Health News:ViroPharma Incorporated Reports First Quarter 2008 Financial Results 3Health News:ViroPharma Incorporated Reports First Quarter 2008 Financial Results 4Health News:ViroPharma Incorporated Reports First Quarter 2008 Financial Results 5Health News:ViroPharma Incorporated Reports First Quarter 2008 Financial Results 6Health News:ViroPharma Incorporated Reports First Quarter 2008 Financial Results 7Health News:ViroPharma Incorporated Reports First Quarter 2008 Financial Results 8Health News:ViroPharma Incorporated Reports First Quarter 2008 Financial Results 9Health News:ViroPharma Incorporated Reports First Quarter 2008 Financial Results 10Health News:Genoptix Announces Participation at the Bank of America 2008 Healthcare Conference 2Health News:BioForm Medical Acquires Facial Aesthetic Nerve Ablation Technology 2Health News:BioForm Medical Acquires Facial Aesthetic Nerve Ablation Technology 3Health News:BioForm Medical Acquires Facial Aesthetic Nerve Ablation Technology 4Health News:BioForm Medical Acquires Facial Aesthetic Nerve Ablation Technology 5Health News:BASF Podcast: The Chemical Reporter - Why do You Get Garlic Breath? 2Health News:Celebrity Mom Kimberly Williams-Paisley Gets Kids to Eat Their Veggies 2Health News:Celebrity Mom Kimberly Williams-Paisley Gets Kids to Eat Their Veggies 3Health News:Celebrity Mom Kimberly Williams-Paisley Gets Kids to Eat Their Veggies 4Health News:Celebrity Mom Kimberly Williams-Paisley Gets Kids to Eat Their Veggies 5Health News:Celebrity Mom Kimberly Williams-Paisley Gets Kids to Eat Their Veggies 6Health News:Celebrity Mom Kimberly Williams-Paisley Gets Kids to Eat Their Veggies 7
(Date:11/30/2009)...BOTHELL, Wash., Nov. 30 ...day that on November 25, 2009, the NYSE Amex LLC (...ccepted the Company,s plan to comply with its prev...1003(a)(iv) of the Exchange Company Guide. Specif...any sustained losses which were so substantial in ...
(Date:11/30/2009)..., NEW YORK, Nov. 30 Reportlinker...s available in its catalogue: ,, Cardiac Defib... ,, http://www.reportlinker.com/p0164315/Card...ce-Report.html ,, Cardiovascular disease (CVD...y. Sudden cardiac arrest survivors are prone to ar...
(Date:11/30/2009)..., NEW YORK, Nov. 30 Reportlinker...s available in its catalogue: ,, Outsourcing O...,, http://www.reportlinker.com/p0165747/Outsou..., Report Description ,, Medical devices form...r with an estimated size of $250 billion in 2009 a...
Breaking Medicine Technology:SCOLR Pharma, Inc. Receives Notices From NYSE Amex LLC Regarding Compliance Plan and Listing Standards 2SCOLR Pharma, Inc. Receives Notices From NYSE Amex LLC Regarding Compliance Plan and Listing Standards 3SCOLR Pharma, Inc. Receives Notices From NYSE Amex LLC Regarding Compliance Plan and Listing Standards 4Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 2Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 3Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 4Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 5Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 6Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 7Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 8Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 2Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 3Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 4Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 5Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 6Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 7Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 8Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 9Macomb County Announces Another H1N1 Flu Vaccine Clinic Saturday Nov 7 3B Both Types of Vaccine Available for Free 60569 1Macomb County Announces Another H1N1 Flu Vaccine Clinic Saturday Nov 7 3B Both Types of Vaccine Available for Free 60569 2Additional Specialized Radiation Not Necessary for Some Women After Mastectomy 5936 1Additional Specialized Radiation Not Necessary for Some Women After Mastectomy 5936 2Additional Specialized Radiation Not Necessary for Some Women After Mastectomy 5936 3Obesity Significantly Increases Side Effects of Stereotactic Body Radiation Therapy in Lung Cancer Patients 5934 1Obesity Significantly Increases Side Effects of Stereotactic Body Radiation Therapy in Lung Cancer Patients 5934 2Obesity Significantly Increases Side Effects of Stereotactic Body Radiation Therapy in Lung Cancer Patients 5934 3
...s., April 30 Cequent Pharmaceuticals, a,pioneer i...i-based,treatments to prevent and treat human dise..., Johannes Fruehauf, MD, Ph.D., is slated to speak... presentation, "Treatment of,Gastrointestinal Targ... pm,on Friday, May 2, at the Hilton Boston Logan A...
...l., April 30 AstraZeneca (NYSE:,AZN) today announ...ication,(sNDA) to the U.S. Food and Drug Administr...YMBICORT(R) (budesonide/formoterol fumarate dihydr...nts with Chronic Obstructive,Pulmonary Disease (CO...term,maintenance treatment of asthma in patients 1...
Other Medicine Technology:Cequent Pharmaceuticals' Johannes Fruehauf, MD, Ph.D., to be Featured Speaker at RNAi World Congress in Boston - May 2, 2008 2Cequent Pharmaceuticals' Johannes Fruehauf, MD, Ph.D., to be Featured Speaker at RNAi World Congress in Boston - May 2, 2008 3AstraZeneca Submits an sNDA for SYMBICORT(R) for COPD Indication 2AstraZeneca Submits an sNDA for SYMBICORT(R) for COPD Indication 3AstraZeneca Submits an sNDA for SYMBICORT(R) for COPD Indication 4AstraZeneca Submits an sNDA for SYMBICORT(R) for COPD Indication 5
Murdoch Eye Speculum
Cook Eye Speculum - Infant
Mellinger Eye Speculum
Lindstrom Eye Speculum - Aspirating
Medicine Products: